172 related articles for article (PubMed ID: 37255899)
1. Histomorphological Analysis of Ovarian Neoplasms According to the 2020 WHO Classification of Ovarian Tumors: A Distribution Pattern in a Tertiary Care Center.
Mehra P; Aditi S; Prasad KM; Bariar NK
Cureus; 2023 Apr; 15(4):e38273. PubMed ID: 37255899
[TBL] [Abstract][Full Text] [Related]
2. Distribution of various histopathological types of ovarian tumors: A study of 212 cases from a tertiary care center of Eastern Uttar Pradesh.
Gupta N; Yadav M; Gupta V; Chaudhary D; Patne SCU
J Lab Physicians; 2019; 11(1):75-81. PubMed ID: 30983807
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of ovarian tumors: Histopathological study of 218 cases.
Mansoor NA; Jezan HS
Gulf J Oncolog; 2015 May; 1(18):64-70. PubMed ID: 26003107
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Tumors: Pattern of Histomorphological Types- A 10 Years Study in a Tertiary Referral Center and Review of Literature.
Ghosh A; Ghartimagar D; Thapa S; Sathian B; Narasimhan R; Talwar OP
Kathmandu Univ Med J (KUMJ); 2016; 14(54):153-158. PubMed ID: 28166073
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
7. Pathological Features of Ovarian Tumors, Diagnosed at a Tertiary Care Hospital in Afghanistan: A Cross-sectional Study.
Ibrahimkhil AS; Malakzai HA; Haidary AM; Hussaini N; Abdul-Ghafar J
Cancer Manag Res; 2022; 14():3325-3333. PubMed ID: 36465710
[TBL] [Abstract][Full Text] [Related]
8. Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10-year study in a tertiary hospital of eastern India.
Mondal SK; Banyopadhyay R; Nag DR; Roychowdhury S; Mondal PK; Sinha SK
J Cancer Res Ther; 2011; 7(4):433-7. PubMed ID: 22269405
[TBL] [Abstract][Full Text] [Related]
9. Histopathological Spectrum of Ovarian Neoplasms: A Single-Center Study.
Batool A; Rathore Z; Jahangir F; Javeed S; Nasir S; Chughtai AS
Cureus; 2022 Jul; 14(7):e27486. PubMed ID: 36060370
[TBL] [Abstract][Full Text] [Related]
10. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
11. Histopathological pattern of ovarian neoplasms and their age distribution in the western region of Saudi Arabia.
Abdullah LS; Bondagji NS
Saudi Med J; 2012 Jan; 33(1):61-5. PubMed ID: 22273650
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors: an institutional perspective.
Hashmi AA; Hussain ZF; Bhagwani AR; Edhi MM; Faridi N; Hussain SD; Khan M
BMC Res Notes; 2016 Apr; 9():205. PubMed ID: 27052022
[TBL] [Abstract][Full Text] [Related]
13. Different features of the histopathological subtypes of ovarian tumors in pre- and postmenopausal women.
Jung EJ; Eom HM; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
Menopause; 2017 Sep; 24(9):1028-1032. PubMed ID: 28832426
[TBL] [Abstract][Full Text] [Related]
14. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
[TBL] [Abstract][Full Text] [Related]
15. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
16. Clinico-histopathological analysis of neoplastic and non-neoplastic lesions of the ovary: a 3-year prospective study in dhule, north maharashtra, India.
S N K; N V D; P N D; D B N; K H S
J Clin Diagn Res; 2014 Aug; 8(8):FC04-7. PubMed ID: 25302198
[TBL] [Abstract][Full Text] [Related]
17. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
Saygili U; Uslu T; Erten O; Doğan E
Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
[TBL] [Abstract][Full Text] [Related]
18. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
19. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
